SCHEMBL547643

SCHEMBL547643

CCOC(=O)CCCCCC(C(=O)Nc1ccccc1)C(=O)Nc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.61
HDAC2 Q92769 9/20 0.51
HDAC8 Q9BY41 8/20 0.49
HDAC3 O15379 6/20 0.49
HDAC6 Q9UBN7 6/20 0.49
HDAC1 Q13547 5/20 0.49
HDAC4 P56524 4/20 0.49
HDAC7 Q8WUI4 4/20 0.49
HDAC10 Q969S8 4/20 0.49
HDAC11 Q96DB2 4/20 0.49
HDAC9 Q9UKV0 4/20 0.49
HDAC5 Q9UQL6 4/20 0.49
SIRT2 Q8IXJ6 1/20 0.47
SIRT1 Q96EB6 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
TP53 P04637 1/20 0.47
NPY1R P25929 1/20 0.46
NPY2R P49146 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL547692 0.82 HDAC2 (0.57) HDAC2HDAC8HDAC3HDAC6HDAC1
SCHEMBL28855893 0.80 ALDH1A1 (0.70) ALDH1A1HDAC2HDAC8HDAC3HDAC6
SCHEMBL10048315 0.80 ALDH1A1 (0.53) ALDH1A1TP53NPY1RNPY2RTSHR
SCHEMBL8200430 0.78 HDAC2 (0.77) HDAC2HDAC8HDAC3HDAC6HDAC1
SCHEMBL3067050 0.77 HPGD (0.66) ALDH1A1HDAC2HDAC8HDAC3HDAC6
SCHEMBL15741881 0.77 ALDH1A1 (0.97) ALDH1A1HDAC2HDAC8HDAC3HDAC6
SCHEMBL8296171 0.77 HDAC2 (0.64) ALDH1A1HDAC2HDAC8HDAC3HDAC6
SCHEMBL27688343 0.77 ALDH1A1 (0.50) ALDH1A1TP53NPY1RNPY2RTSHR
SCHEMBL14264185 0.77 HDAC2 (0.52) HDAC2HDAC8HDAC3HDAC6HDAC1
SCHEMBL11514409 0.76 CYP1A2 (0.52) ALDH1A1CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8110577-B2 Histone deacetylase inhibitors QUEEN MARY & WESTFIELD COLLEGE (GB) 2012-02-07 US disclosed
US-8110577-B2 Histone deacetylase inhibitors QUEEN MARY & WESTFIELD COLLEGE (GB) 2012-02-07 US disclosed
US-8110577-B2 Histone deacetylase inhibitors QUEEN MARY & WESTFIELD COLLEGE (GB) 2012-02-07 US disclosed
US-20100160392-A1 HISTONE DEACETYLASE INHIBITORS QUEEN MARY & WESTFIELD COLLEGE (GB) 2010-06-24 US disclosed
US-20100160392-A1 HISTONE DEACETYLASE INHIBITORS QUEEN MARY & WESTFIELD COLLEGE (GB) 2010-06-24 US disclosed
US-20100160392-A1 HISTONE DEACETYLASE INHIBITORS QUEEN MARY & WESTFIELD COLLEGE (GB) 2010-06-24 US disclosed
EP-2086950-A2 HISTONE DEACETYLASE INHIBITORS Queen Mary and Westfield College (GB) 2009-08-12 EP disclosed
WO-2008047138-A2 HISTONE DEACETYLASE INHIBITORS QUEEN MARY AND WESTFIELD COLLEGE (GB) 2008-04-24 WO disclosed
WO-2008047138-A2 HISTONE DEACETYLASE INHIBITORS QUEEN MARY AND WESTFIELD COLLEGE (GB) 2008-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160392-A1 HISTONE DEACETYLASE INHIBITORS HDAC3, HDAC1, HDAC4 ALDH1A1 2757/4885HDAC2 4/4885HDAC8 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.